Blood test guides chemo to stop deadly cancer return
NCT ID NCT07188025
Summary
This study is testing whether giving chemotherapy after surgery can prevent rectal cancer from returning in patients who are at high risk. Researchers will use a special blood test to identify patients who have tiny amounts of cancer DNA left after their operation. About 103 patients who test positive will be randomly assigned to receive either standard monitoring or additional chemotherapy to try to eliminate any remaining cancer cells and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.